Waldencast PLC - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

More Details of Waldencast PLC Company

Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical is an advanced skin care line rooted in research and skin biology. It provides treatment of hyperpigmentation with the Obagi Medical Nu-Derm System. The Obagi Medical products are designed to diminish the appearance of premature aging, photodamage, skin discoloration, acne, and sun damage. The Milk Makeup segment is a makeup brand, which offers a selection of both makeup and skincare products. Its products include Matte Bronzer, Hydro Grip Set + Refresh Spray, Kush Mascara, Kush Brow and Pore Eclipse Primer. Milk Makeup offers over 300 products through its United States Website, www.MilkMakeup.com, and its retail partners, including Sephora in North America, Europe, the Middle East and Australia and Cult Beauty and Selfridges in the United Kingdom.

Waldencast PLC Info



Ticker SymbolWALD

Company nameWaldencast PLC

IPO dateMar 18, 2021

CEOMr. Michel Brousset

Number of employees332

Security typeOrdinary Share

Fiscal year-endMar 18

AddressMichelin House, 81 Fulham Road

CityLONDON

Stock exchangeNASDAQ Capital Market Consolidated

CountryUnited Kingdom

Postal codeSW3 6RD

Phone

Websitehttps://www.waldencast.com/

Ticker SymbolWALD

IPO dateMar 18, 2021

CEOMr. Michel Brousset

Company Executives of Waldencast PLC



Name

Name/Position

Position

Shareholding

Change

Mr. Michel Brousset

Chief Executive Officer, Director

2.90M

--

Mr. Aaron Chatterley

Independent Director

20.00K

--

Ms. Juliette Hickman

Independent Director

20.00K

--

Ms. Hind Sebti

Chief Growth Officer, Director

20.00K

--

Ms. Lindsay Pattison

Independent Director

20.00K

--

Mr. Zachary (Zack) Werner

Independent Director

--

Mr. Simon Dailley

Director

--

Mr. Cristiano Souza

Director

--

Ms. Kelly Brookie

Independent Director

--

Mr. Manuel Manfredi

Chief Financial Officer

--

Name

Name/Position

Position

Shareholding

Change

Mr. Michel Brousset

Chief Executive Officer, Director

2.90M

--

Mr. Aaron Chatterley

Independent Director

20.00K

--

Ms. Juliette Hickman

Independent Director

20.00K

--

Ms. Hind Sebti

Chief Growth Officer, Director

20.00K

--

Ms. Lindsay Pattison

Independent Director

20.00K

--

Mr. Zachary (Zack) Werner

Independent Director

--

Revenue Breakdown

Currency: USDUpdated: Thu, Oct 2

FY2024

FY2023

FY2022

FY2022Q2

FY2022Q1

FY2021

FY2021Q4

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Product sales

269.37M

98.36%

Royalties

4.50M

1.67%

By RegionUSD

Name

Revenue

Proportion

North America

202.26M

75.09%

Rest of the World

67.11M

24.91%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Product sales

269.37M

98.36%

Royalties

4.50M

1.67%

Shareholding Stats

Updated: Sat, Aug 23

Shareholders

Shareholder Types

Shareholders

Proportion

Cedarwalk Skincare Ltd

25.42%

Zeno Equity Partners LLP

14.02%

Arbitrage Ltd

8.88%

Waldencast Long-Term Capital LLC

8.26%

Burwell Mountain Trust

6.97%

Other

36.45%

Shareholders

Proportion

Cedarwalk Skincare Ltd

25.42%

Zeno Equity Partners LLP

14.02%

Arbitrage Ltd

8.88%

Waldencast Long-Term Capital LLC

8.26%

Burwell Mountain Trust

6.97%

Other

36.45%

Shareholder Types

Shareholders

Proportion

Corporation

54.33%

Hedge Fund

14.09%

Investment Advisor

8.39%

Private Equity

5.41%

Individual Investor

2.68%

Investment Advisor/Hedge Fund

2.12%

Research Firm

0.15%

Bank and Trust

0.07%

Pension Fund

0.02%

Other

12.75%

Institutional Shareholding



Updated: Wed, Oct 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q3

135

34.06M

30.24%

-10.95M

2025Q2

146

93.35M

82.94%

-3.39K

2025Q1

148

93.02M

82.58%

-230.78K

2024Q4

144

78.12M

69.70%

-17.61M

2024Q3

135

86.17M

77.32%

-10.93M

2024Q2

172

87.50M

78.73%

-27.82M

2024Q1

176

82.86M

81.85%

-41.80M

2023Q4

166

82.66M

81.66%

-28.79M

2023Q3

155

85.92M

95.07%

-24.54M

2023Q2

141

83.77M

96.89%

-26.04M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Cedarwalk Skincare Ltd

28.64M

25.42%

--

Feb 28, 2025

Zeno Equity Partners LLP

15.79M

14.02%

+454.72K

+2.97%

Jul 29, 2025

Arbitrage Ltd

10.00M

8.88%

+10.00M

--

Feb 28, 2025

Waldencast Long-Term Capital LLC

9.31M

8.26%

--

Feb 28, 2025

Burwell Mountain Trust

7.85M

6.97%

--

Feb 28, 2025

Main Post Partners, L.P.

6.09M

5.41%

--

Feb 28, 2025

Annapurna Investment Fund Ltd.

5.40M

4.8%

+73.14K

+1.37%

Aug 15, 2025

Fitpart Fund Administration Services Ltd

3.45M

3.06%

+3.45M

--

Aug 15, 2025

Brousset (Michel)

2.90M

2.57%

--

Feb 28, 2025

Milestones Administradora de Recursos Ltda.

2.20M

1.95%

--

Jun 30, 2025

Related ETFs



Updated: Thu, Oct 2

Name

Proportion

Global X Russell 2000 Covered Call ETF

0%

Avantis US Small Cap Equity ETF

0%

iShares Russell 2000 Value ETF

0%

Global X Russell 2000 ETF

0%

ProShares Hedge Replication ETF

0%

iShares Russell 3000 ETF

0%

Proshares Ultra Russell 2000

0%

ProShares UltraPro Russell2000

0%

iShares Russell 2000 ETF

0%

Global X Russell 2000 Covered Call ETF

Proportion0%

Avantis US Small Cap Equity ETF

Proportion0%

iShares Russell 2000 Value ETF

Proportion0%

Global X Russell 2000 ETF

Proportion0%

ProShares Hedge Replication ETF

Proportion0%

iShares Russell 3000 ETF

Proportion0%

Proshares Ultra Russell 2000

Proportion0%

ProShares UltraPro Russell2000

Proportion0%

iShares Russell 2000 ETF

Proportion0%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split



Date

Type

Ratio

No Data

Date

Type

Ratio

No Data